NOTE 5 - CAPITAL STOCK (Details) - USD ($)			1 Months Ended
	Apr. 02, 2019	Dec. 31, 2014	Mar. 31, 2015	Jun. 30, 2022	Dec. 31, 2021	Sep. 30, 2017
Common Stock, Shares Authorized				100,000,000	100,000,000
Common Stock, Par or Stated Value Per Share				$ 0.0001	$ 0.0001
Proceeds from issuance of restricted shares	$ 14,490
Restricted common stock issued	21,000
Common Stock, Shares, Issued				26,221,000	26,221,000
Redfield Holdings Ltd
Preferred Stock, Voting Rights			Each share of preferred shares – Series “A” carries voting right equal to 10,000 common shares
Convertible Notes Payable | Redfield Holdings Ltd
Amount Subscribed By Related Party Against Cancellation Of Note			$ 58,000
GS Pharmaceuticals, Inc.
Principal amount of note outstanding		$ 330,000
Preferred Class A
Preferred Stock, Shares Authorized				20,000,000	20,000,000
Preferred Stock, Par or Stated Value Per Share				$ 0.0001	$ 0.0001
Series B Preferred Stock
Redeemable Preferred Stock, Shares Authorized				500,000	500,000
Redeemable Preferred Stock, Shares Issued				330,000	0	330,000
Redeemable Preferred Stock, Shares Outstanding				330,000	0	330,000
Redeemable Preferred Stock				$ 330,000	$ 330,000
Series B Preferred Stock | GS Pharmaceuticals, Inc.
Preferred shares issued upon conversion of debt		330,000
Series A Preferred Stock
Redeemable Preferred Stock, Shares Issued						10,000
Redeemable Preferred Stock, Shares Outstanding						10,000
Series C Preferred Stock
Redeemable Preferred Stock, Shares Authorized				500,000	500,000
Redeemable Preferred Stock, Shares Issued				470,935	0
Redeemable Preferred Stock, Shares Outstanding				470,935	0
Redeemable Preferred Stock				$ 470,935	$ 470,935